Tech Company Financing Transactions
Signum Biosciences Funding Round
Signum Biosciences closed a $4 million financing round on 9/30/2011. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/30/2011
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4999 Pearl East Cir.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from our phosphatase platform to modulate signal transduction imbalances.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maxwell Stock
Chief Scientific Officer
Eduardo Perez
Vice President
Michael Voronkov
VP - Product Management
Masanori Tamura
VP - R & D
Jose Fernandez
Browse more venture capital transactions:
Prev: 9/30/2011: Virtual Computer venture capital transaction
Next: 9/30/2011: XOS Digital venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs